For decades, this condition was known as Polycystic Ovary Syndrome, or PCOS. In 2026, it was renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), following an eleven-year global consensus process involving more than 50 patient and professional organisations.1,2
This isn't just a name change. It's a reframe. One validating that it was never only about the ovarian cysts, but about the entire metabolic-endocrine system and the way its parts interact.
Why the name changed
The old name centred the condition around ovarian cysts, with diagnostic criteria requiring two of the following: ovarian cysts, signs and symptoms of elevated testosterone, and anovulation.3 The new name, PMOS, points to what research has increasingly shown: this is a polyendocrine condition, meaning it involves multiple biological and physiological systems, not just the ovaries, and it carries significant metabolic consequences, including insulin resistance, weight regulation difficulties and increased cardiovascular risk over time.1,2
That broader picture matters for how we treat it, and especially for how we prescribe exercise. Especially as exercise and diet have been named first-line treatment, not an add-on, in the international guidelines.3,4
Why “just exercise more” doesn't work
Women with PMOS are often told to exercise for weight loss or symptom management, but generic advice like “move more” or “try cardio” misses the physiology entirely. PMOS involves insulin resistance, hormonal fluctuation and, for many women, a heightened stress response, one that has possibly been fuelling the dysregulation leading to increased severity in symptoms.5
Exercise that ignores these factors can do more harm than good: excessive high-intensity training can raise cortisol and worsen hormonal imbalance,6,7 while purely aerobic-focused programmes often fail to address the insulin resistance that sits at the centre of the condition.4 The main missing link: individualised approaches when it comes to movement that is actually prescribed at a clinical dose.
This is where clinically dosed exercise prescription comes in.
What clinical dosing actually means
Dosing exercise clinically means treating training variables (intensity, volume, frequency and recovery) the way a clinician treats medication: matched to the individual, adjusted over time and monitored for response.
For a woman with PMOS, that might mean:
- Establishing baseline strength levels consistently to reduce injury risk associated with higher levels of inflammation
- Prioritising resistance training to improve insulin sensitivity and support long-term metabolic health4,8
- Balancing training stress with recovery to avoid additional cortisol load6,7
- Adjusting each session based on how the patient presents that day — energy, fatigue, sleep and stress all inform what that session should actually look like — rather than sticking rigidly to a pre-set plan
- Incorporating cardio that is manageable with levels of fatigue and burnout
- Progressing gradually, with reassessment built in, rather than defaulting to a generic “more is better” approach
This is fundamentally different from a general gym programme, and it's why exercise prescription for PMOS benefits from being led by someone trained to assess and adjust for the underlying physiology and pathophysiology, not just the symptoms on the surface.4
Where to start
You don't need to wait for an appointment to start paying attention to how your body is responding to exercise. A few things worth noticing:
Signs your current exercise routine may not be dosed for PMOS
- You feel wiped out for the rest of the day after workouts, rather than energised
- Your cycle has become more irregular since increasing training intensity or frequency
- You've plateaued despite being consistent, or symptoms seem to be getting worse, not better
- Your routine leans almost entirely on daily high-intensity cardio, with little to no resistance training or recovery built in
A simple first step
Before changing anything, spend two weeks tracking how you feel after each workout, not just what you did. Energy levels, sleep quality and mood are often the first signals that a training load is working with your physiology or against it.
Questions worth asking at a clinical assessment
- How will my programme adjust from session to session based on how I'm actually showing up that day, rather than following a fixed plan regardless?
- What baseline testing will be used to track whether this is working?
- How is recovery being built into the plan, not just training?
None of this replaces a proper clinical assessment, but it gives you a starting point for noticing what's actually happening in your body, which is often the first step toward asking for a different approach.
The bigger point
PMOS Awareness Month is an opportunity to move the conversation past cysts and periods, and toward the full metabolic and hormonal picture. It falls inside The Pink Initiative, our women's health season running August to October.
For the women living with it, that shift matters.
It's the difference between an exercise plan that works with the body's actual physiology and one that guesses.
Start with an assessment
If you're navigating a PMOS diagnosis and unsure where to start, a clinical assessment with a registered biokineticist is a good first step before any exercise plan is built around it.
References
- Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet, 2026.
- Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: new name to improve diagnosis and care of condition affecting 170 million women worldwide. May 2026.
- International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, 2023. Monash University, on behalf of the international guideline development groups.
- Exercise and Sports Science Australia. Exercise in the management of polycystic ovary syndrome: a position statement. 2024.
- Cortisol dysregulation and androgen production in PMOS: reported in clinical commentary, The Week, July 2026.
- Ramezani Ahmadi A, et al. Effects of HIIT on metabolic, hormonal and cardiovascular indices in women with PCOS. BMC Sports Science, Medicine and Rehabilitation, 2023.
- National Strength and Conditioning Association. The impact of polycystic ovarian syndrome on female athlete performance and overall health. NSCA Coach.
- Cowan S, et al. Lifestyle management in polycystic ovary syndrome: beyond diet and physical activity. BMC Endocrine Disorders, 2023.
